Validation of the ABILHAND questionnaire to measure manual ability in children and adults with neuromuscular disorders

Vandervelde, Laure; Bergh, Peter Van den; Penta, Massimo; Thonnard, Jean-Louis

doi:10.1136/jnnp.2009.177055

Cited by 55 publications

(59 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It was initially developed and validated for persons with rheumatoid arthritis [16] and then for persons with chronic stroke [17] as well as for several other diagnosis [18][19][20][21][22]. The ABILHAND Questionnaire is reliable in a test-retest situation in persons with rheumatoid arthritis and in persons with systemic sclerosis [19,23,24].…”

Section: Introductionmentioning

confidence: 99%

Test‐Retest Reliability of the ABILHAND Questionnaire in Persons With Chronic Stroke

Ekstrand

Lindgren

Lexell

et al. 2013

PM&R

View full text Add to dashboard Cite

BackgroundReliable and valid outcome measures are needed to be able to evaluate recovery, effects of rehabilitation interventions, and changes over time. The ABILHAND Questionnaire is a measure of a patient's self‐reported ability to perform complex daily activities involving use of the hand. This instrument is commonly used in stroke rehabilitation settings, but data about the measurement variability are missing.ObjectiveTo assess the test‐retest reliability of the ABILHAND Questionnaire in persons with chronic stroke and to define limits for the smallest change that indicates a real change, both for a group of individuals and for a single individual.DesignA test‐retest reliability study.SettingsUniversity hospital.ParticipantsA convenience sample of 43 persons (11 women and 32 men; mean age 64 years) with mild to moderate impairments of hand function 6‐48 months after sustaining a stroke.InterventionNot applicable.Main Outcome MeasurementsThe ABILHAND Questionnaire is Rasch analyzed, enabling ordinal data to be converted into an interval scale (logits) and the use of parametric statistical analyses. The participants responded to 23 items in the ABILHAND Questionnaire on 2 occasions, 2 weeks apart. Reliability was assessed with the intraclass correlation coefficient (ICC22.1), the mean difference between the test sessions (đ) together with the 95% confidence intervals for đ, the standard error of measurement (SEM and SEM%), the smallest real difference (SRD and SRD%), and a Bland and Altman graph.ResultsFour outliers with high mean logit scores (>4.0) were identified in the sample. The results therefore are presented both for the entire sample (n = 43) and without the 4 outliers (n = 39). The test‐retest agreement was high: ICC2,1 = 0.85 (n = 43) and 0.91 (n = 39). The SEM%, which represents the smallest change that indicates a real improvement for a group of individuals, was 21% (n = 43) and 15% (n = 39). The SRD%, which represents the smallest change that indicates a real clinical improvement for a single individual, was 59% (n = 43) and 42% (n = 39), respectively.ConclusionThe ABILHAND Questionnaire is reliable in persons with chronic stroke and can be recommended to evaluate recovery, rehabilitation interventions, and changes over time in a group of individuals but is less suitable for a single individual.

show abstract

Section: Introductionmentioning

confidence: 99%

Test‐Retest Reliability of the ABILHAND Questionnaire in Persons With Chronic Stroke

Ekstrand

Lindgren

Lexell

et al. 2013

PM&R

View full text Add to dashboard Cite

show abstract

“…6 Disease-specific manual ability 'rulers' were previously developed for the following patient groups: chronic stroke (CS), 6 cerebral palsy (CP), 7 rheumatoid arthritis (RA), 8 systemic sclerosis (SSc) 9 and neuromuscular disorders (NMD). 10 Each ABILHAND scale has its own Rasch-derived item difficulty calibration, which defines a disease-specific manual ability measurement continuum. ABILHAND questionnaires present good psychometric qualities, including linearity, unidimensionality, construct validity, and test-retest reliability.…”

Section: Introductionmentioning

confidence: 99%

Can manual ability be measured with a generic ABILHAND scale? A cross-sectional study conducted on six diagnostic groups

et al. 2012

View full text Add to dashboard Cite

ObjectivesSeveral ABILHAND Rasch-built manual ability scales were previously developed for chronic stroke (CS), cerebral palsy (CP), rheumatoid arthritis (RA), systemic sclerosis (SSc) and neuromuscular disorders (NMD). The present study aimed to explore the applicability of a generic manual ability scale unbiased by diagnosis and to study the nature of manual ability across diagnoses.DesignCross-sectional study.SettingOutpatient clinic homes (CS, CP, RA), specialised centres (CP), reference centres (CP, NMD) and university hospitals (SSc).Participants762 patients from six diagnostic groups: 103 CS adults, 113 CP children, 112 RA adults, 156 SSc adults, 124 NMD children and 124 NMD adults.Primary and secondary outcome measuresManual ability as measured by the ABILHAND disease-specific questionnaires, diagnosis and nature (ie, uni-manual or bi-manual involvement and proximal or distal joints involvement) of the ABILHAND manual activities.ResultsThe difficulties of most manual activities were diagnosis dependent. A principal component analysis highlighted that 57% of the variance in the item difficulty between diagnoses was explained by the symmetric or asymmetric nature of the disorders. A generic scale was constructed, from a metric point of view, with 11 items sharing a common difficulty among diagnoses and 41 items displaying a category-specific location (asymmetric: CS, CP; and symmetric: RA, SSc, NMD). This generic scale showed that CP and NMD children had significantly less manual ability than RA patients, who had significantly less manual ability than CS, SSc and NMD adults. However, the generic scale was less discriminative and responsive to small deficits than disease-specific instruments.ConclusionsOur finding that most of the manual item difficulties were disease-dependent emphasises the danger of using generic scales without prior investigation of item invariance across diagnostic groups. Nevertheless, a generic manual ability scale could be developed by adjusting and accounting for activities perceived differently in various disorders.

show abstract

“…Again, validation in larger groups of patients from widespread geographical origin needs to be considered. In MMN in particular, feedback of the patients on the questionnaire items may be helpful to refine it and the study of existing Rasch-based scales such as Abilhand (Vandervelde et al, 2010) may lead to an additional tool. Third, GBS, CIDP, and MGUSP were lumped together, supposing that they are similar conditions.…”

Section: Discussionmentioning

confidence: 99%

“…Ideally, these patients should be included before the start of IVIG treatment. The Rasch-built ABILHAND questionnaire (Vandervelde et al, 2010), which was designed to measure manual ability in children and adults with neuromuscular disorders, might be tested in MMN and compared with the MMN-RODS in future clinical trials (Vandervelde et al, 2010).…”

Section: Multifocal Motor Neuropathymentioning

confidence: 99%

Future needs in peripheral neuropathy outcome measures

Bergh¹,

Lunn

2015

J Peripheral Nervous Sys

View full text Add to dashboard Cite

Validation of the ABILHAND questionnaire to measure manual ability in children and adults with neuromuscular disorders

Abstract: This scale can be used for adults and children, allowing manual ability to be assessed from childhood to adulthood.

Cited by 55 publications

References 25 publications

Test‐Retest Reliability of the ABILHAND Questionnaire in Persons With Chronic Stroke

Test‐Retest Reliability of the ABILHAND Questionnaire in Persons With Chronic Stroke

Can manual ability be measured with a generic ABILHAND scale? A cross-sectional study conducted on six diagnostic groups

Future needs in peripheral neuropathy outcome measures

Contact Info

Product

Resources

About